Kester, Kent E <br/><br/>
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.  [electronic resource] 

 -  Vaccine  Jul 2007 
 - 5359-66 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2007.05.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Protozoan--blood<br/>Cell Proliferation<br/>Cells, Cultured<br/>Chemistry, Pharmaceutical<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Freeze Drying<br/>Humans<br/>Immunoglobulin G--blood<br/>Leukocytes, Mononuclear--immunology<br/>Malaria--immunology<br/>Malaria Vaccines--administration & dosage<br/>Male<br/>Middle Aged<br/>Parasitemia